EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium‐177 PSMA

John Y Kwon iD, John C Cheville iD, Miguel Muniz-Rincon iD, Mohamed E Ahmed, Eugene D Kwon, Irbaz Riaz iD, Dan S Childs iD, Geoffrey Johnson iD, Oliver Sartor iD, Lance C Pagliaro iD, Jacob J Orme iD

Case Reports in Urology · 2026-01 · 2026 (1)

DOI: 10.1155/criu/1304419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Urology, online erschienen am 05.08.2026. Verfasst von John Y Kwon und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pleomorphic giant cell carcinoma (PGCC) of the prostate is an extremely rare and aggressive malignancy with limited treatment options. We present a case report of metastatic PGCC patients treated with 177 Lu‐PSMA‐617 radioligand therapy (Pluvicto) after progression on standard therapies. Both patients had PSMA‐avid tumors on imaging. Molecular profiling revealed mutations in hallmark tumor suppressors including TP53, RB1, and PTEN. Both patients initially experienced partial radiographic response, in which one patient achieved stable disease for 9 months posttherapy. These findings suggest that PSMA‐radioligand therapy may be a reasonable treatment for PGCC patients, but underscore the need for additional therapeutic options.

Schlagwörter

Stichwörter der Autor:innen

PGCCPluvictolutetium-177-PSMApleomorphic giant cellpleomorphic giant cell carcinomaprostate cancerradioligand therapy

Autor:innen und Institutionen

  • Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
  • Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
  • Department of Urology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
  • Department of Internal Medicine, Division of Oncology, Mayo Clinic, Phoenix, Arizona, USA, mayo.edu.
  • Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.

ORCID-Profile: John Y Kwon, John C Cheville, Miguel Muniz-Rincon, Irbaz Riaz, Dan S Childs, Geoffrey Johnson, Oliver Sartor, Lance C Pagliaro, Jacob J Orme

Zitieren

APA

Kwon, J. Y., Cheville, J. C., Muniz-Rincon, M., Ahmed, M. E., Kwon, E. D., Riaz, I., Childs, D. S., Johnson, G., Sartor, O., Pagliaro, L. C., & Orme, J. J. (2026). Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium‐177 PSMA. Case Reports in Urology, 2026(1). https://doi.org/10.1155/criu/1304419

Vancouver

Kwon JY, Cheville JC, Muniz-Rincon M, Ahmed ME, Kwon ED, Riaz I, et al. Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium‐177 PSMA. Case Reports in Urology. 2026;2026(1). doi:10.1155/criu/1304419

BibTeX
@article{Kwon2026,
  author = {Kwon, John Y and Cheville, John C and Muniz-Rincon, Miguel and Ahmed, Mohamed E and Kwon, Eugene D and Riaz, Irbaz and Childs, Dan S and Johnson, Geoffrey and Sartor, Oliver and Pagliaro, Lance C and Orme, Jacob J},
  title = {Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium‐177 PSMA},
  journal = {Case Reports in Urology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/criu/1304419}
}
Kostenlos starten →